hydroxychloroquine has been researched along with Dermatitis Medicamentosa in 47 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxychloroquine sulfate is a commonly used medication for patients with dermatomyositis and has been associated with a uniquely elevated risk of adverse cutaneous reactions in this population." | 7.88 | Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis. ( Casciola-Rosen, L; Fiorentino, DF; Wolstencroft, PW, 2018) |
| "Hydroxychloroquine sulfate is a commonly used medication for patients with dermatomyositis and has been associated with a uniquely elevated risk of adverse cutaneous reactions in this population." | 3.88 | Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis. ( Casciola-Rosen, L; Fiorentino, DF; Wolstencroft, PW, 2018) |
| "Hydroxychloroquine (HCQ) is an effective treatment of lupus erythematosus." | 2.58 | Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work. ( Kambe, N; Ly, NTM; Matsuda, T; Nguyen, CTH; Okamoto, H; Son, Y; Ueda-Hayakawa, I, 2018) |
| "Sirolimus is an immunosuppressive macrolide with antineoplasic properties that is increasingly used in posttransplantation immunosuppression." | 1.35 | Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis. ( Lübbe, J; Malé, PJ; Masouyé, I; Saurat, JH; Sorg, O, 2008) |
| "Acute generalized exanthematous pustulosis (AGEP) is a disease characterized by the rapid occurrence of many sterile, nonfollicular pustules usually arising on an oedematous erythema often accompanied by leucocytosis and fever." | 1.34 | Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). ( Bavinck, JN; Dunant, A; Fagot, JP; Halevy, S; Mockenhaupt, M; Naldi, L; Roujeau, JC; Sidoroff, A; Viboud, C, 2007) |
| "Hydroxychloroquine (HCQ) is an antimalarial agent with immunomodulatory effects." | 1.33 | Desensitization to hydroxychloroquine--experience of 4 patients. ( Breuer, GS; Mates, M; Navon, P; Nesher, G; Zevin, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.38) | 18.7374 |
| 1990's | 3 (6.38) | 18.2507 |
| 2000's | 7 (14.89) | 29.6817 |
| 2010's | 19 (40.43) | 24.3611 |
| 2020's | 15 (31.91) | 2.80 |
| Authors | Studies |
|---|---|
| Jadeja, S | 1 |
| Temiz, LA | 1 |
| Dewan, AK | 1 |
| Parker, ER | 1 |
| Sharma, AN | 1 |
| Mesinkovska, NA | 1 |
| Paravar, T | 1 |
| Dos Reis Neto, ET | 1 |
| Kakehasi, AM | 1 |
| de Medeiros Pinheiro, M | 1 |
| Ferreira, GA | 1 |
| Marques, CDL | 1 |
| da Mota, LMH | 1 |
| Dos Santos Paiva, E | 1 |
| Pileggi, GCS | 1 |
| Sato, EI | 1 |
| Reis, APMG | 1 |
| Xavier, RM | 1 |
| Provenza, JR | 1 |
| Kuraitis, D | 1 |
| Murina, A | 1 |
| Lipner, SR | 1 |
| Wang, Y | 1 |
| Khurana, A | 1 |
| Katare, A | 1 |
| Agarwal, A | 1 |
| Kathirvel, P | 1 |
| Ahuja, A | 1 |
| Chicharro, P | 1 |
| Rodríguez-Jiménez, P | 1 |
| Muñoz-Aceituno, E | 1 |
| De Argila, D | 1 |
| Muñoz-Hernández, P | 1 |
| Llamas-Velasco, M | 1 |
| Abadías-Granado, I | 1 |
| Palma-Ruiz, AM | 1 |
| Cerro, PA | 1 |
| Morales-Callaghan, AM | 1 |
| Gómez-Mateo, MC | 1 |
| Gilaberte, Y | 1 |
| Schwartz, RA | 1 |
| Redondo-Sendino, Á | 1 |
| González Sánchez, IC | 1 |
| de Victoria Fernández, B | 1 |
| Zekarias, A | 1 |
| Watson, S | 1 |
| Vidlin, SH | 1 |
| Grundmark, B | 1 |
| Kurd, R | 1 |
| Zuckerman, M | 1 |
| Ben-Chetrit, E | 1 |
| Sutton, KM | 1 |
| Fernando, SL | 1 |
| Moya-Martínez, C | 1 |
| Torre-Castro, J | 1 |
| Fariña-Sabarís, MC | 1 |
| Santiago Sánchez-Mateos, D | 1 |
| Eraña-Tomás, I | 1 |
| Jo-Velasco, M | 1 |
| Requena, L | 1 |
| Sánchez-Velázquez, A | 1 |
| Arroyo-Andrés, J | 1 |
| Falkenhain-López, D | 1 |
| Peralto, JLR | 1 |
| Romero, PLO | 1 |
| Díaz, RR | 1 |
| Calleja-Algarra, A | 1 |
| Keita, AM | 1 |
| Zahlane, M | 1 |
| Benjilali, L | 1 |
| Essaadouni, L | 1 |
| Mittal, L | 1 |
| Zhang, L | 1 |
| Feng, R | 1 |
| Werth, VP | 1 |
| Tal, Y | 1 |
| Maoz Segal, R | 1 |
| Langevitz, P | 1 |
| Kivity, S | 1 |
| Darnizki, Z | 1 |
| Agmon-Levin, N | 1 |
| Matsuda, T | 1 |
| Ly, NTM | 1 |
| Kambe, N | 1 |
| Nguyen, CTH | 1 |
| Ueda-Hayakawa, I | 1 |
| Son, Y | 1 |
| Okamoto, H | 1 |
| Randhawa, A | 1 |
| Wylie, G | 1 |
| Kishi, C | 1 |
| Motegi, SI | 1 |
| Yasuda, M | 1 |
| Ishikawa, O | 1 |
| Wolstencroft, PW | 1 |
| Casciola-Rosen, L | 1 |
| Fiorentino, DF | 1 |
| Borik, L | 1 |
| Petzelbauer, P | 1 |
| Quint, T | 1 |
| Wöhrl, S | 1 |
| Kinaciyan, T | 1 |
| Heil, PM | 1 |
| Riley, K | 1 |
| Schwager, Z | 1 |
| Stern, M | 1 |
| Vleugels, RA | 1 |
| Femia, A | 1 |
| Gonzalez, CD | 1 |
| Hansen, C | 1 |
| Clarke, JT | 1 |
| Hayami, T | 1 |
| Tanaka, T | 1 |
| Fujimoto, N | 1 |
| Gardair Bouchy, C | 1 |
| Kerdraon, R | 1 |
| Kluger, N | 1 |
| Armingaud, P | 1 |
| Wakosa, A | 1 |
| Estève, E | 1 |
| Kasper, RS | 1 |
| Flueckiger, B | 1 |
| Gobbi, S | 1 |
| Lautenschlager, S | 1 |
| Borelli, S | 1 |
| Soria, A | 1 |
| Barbaud, A | 2 |
| Assier, H | 1 |
| Avenel-Audran, M | 1 |
| Tétart, F | 1 |
| Raison-Peyron, N | 1 |
| Amarger, S | 1 |
| Girardin, P | 1 |
| Francès, C | 1 |
| Schmutz, JL | 1 |
| Tréchot, P | 1 |
| Avram, MM | 1 |
| Hoang, M | 1 |
| Fain, O | 1 |
| Stirnemann, J | 1 |
| Kettaneh, A | 1 |
| Richmond, BW | 1 |
| Cole, MB | 1 |
| Dash, A | 1 |
| Eyler, A | 1 |
| Boomershine, CS | 1 |
| Caramaschi, P | 1 |
| Barbazza, R | 1 |
| Tinazzi, I | 1 |
| Biasi, D | 1 |
| Abbott, RA | 1 |
| May, K | 1 |
| Motley, RJ | 1 |
| Tang, C | 1 |
| Godfrey, T | 1 |
| Stawell, R | 1 |
| Nikpour, M | 1 |
| Kalampalikis, A | 1 |
| Goetze, S | 1 |
| Elsner, P | 1 |
| Evans, CC | 1 |
| Bergstresser, PR | 1 |
| Mates, M | 1 |
| Zevin, S | 1 |
| Breuer, GS | 1 |
| Navon, P | 1 |
| Nesher, G | 1 |
| Sontheimer, RD | 1 |
| Sidoroff, A | 1 |
| Dunant, A | 1 |
| Viboud, C | 1 |
| Halevy, S | 1 |
| Bavinck, JN | 1 |
| Naldi, L | 1 |
| Mockenhaupt, M | 1 |
| Fagot, JP | 1 |
| Roujeau, JC | 1 |
| Lübbe, J | 1 |
| Sorg, O | 1 |
| Malé, PJ | 1 |
| Saurat, JH | 1 |
| Masouyé, I | 1 |
| Assier-Bonnet, H | 1 |
| Saada, V | 1 |
| Bernier, M | 1 |
| Clerici, T | 1 |
| Saïag, P | 1 |
| O'Reilly, FM | 1 |
| O'Loughlin, S | 1 |
| Murphy, GM | 1 |
| Lotem, M | 1 |
| Ingber, A | 1 |
| Segal, R | 1 |
| Sandbank, M | 1 |
| Hudson, LD | 1 |
| Vlcek, F | 1 |
| Zvaifler, NJ | 1 |
6 reviews available for hydroxychloroquine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review.
Topics: Drug Eruptions; Hair; Humans; Hydroxychloroquine; Nails; Prevalence; Skin | 2020 |
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
Topics: Antimalarials; Antiphospholipid Syndrome; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; | 2020 |
Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Dose-Response Relationship, Drug; Drug Eruptions; | 2018 |
Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.
Topics: Antimalarials; Carbohydrate Metabolism; Cardiovascular Diseases; Chloroquine; Clinical Trials as Top | 2012 |
Acute generalized exanthematous pustulosis induced by hydroxychloroquine.
Topics: Acute Disease; Adult; Antirheumatic Agents; Arthritis; Diagnosis, Differential; Drug Eruptions; Fema | 1996 |
Antimalarials in the treatment of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Chloroquine; Drug Eruptions; Headache; Humans; Hydroxychloroquine; Placebos; | 1971 |
41 other studies available for hydroxychloroquine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A temporal cluster of cutaneous drug eruptions developing after initiation of hydroxychloroquine.
Topics: Drug Eruptions; Exanthema; Humans; Hydroxychloroquine; Skin | 2022 |
Facts, not Fear: Safety of Hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Agranulocytosis; Anemia, Aplastic; Antirheumatic Agents; | 2020 |
Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Child; Child, P | 2020 |
Hydroxychloroquine-induced erythroderma: A rare adverse effect of a commonly used drug.
Topics: Dermatitis, Exfoliative; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Humans; Hy | 2020 |
SDRIFE-like rash associated with COVID-19, clinicopathological correlation.
Topics: Aged; Antiviral Agents; Azithromycin; Chloroquine; COVID-19 Drug Treatment; Drug Eruptions; Exanthem | 2021 |
Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.
Topics: Antimalarials; COVID-19 Drug Treatment; Drug Eruptions; Erythema; Female; Humans; Hydroxychloroquine | 2021 |
[Skin manifestations associated with the new coronavirus SARS-CoV-2 disease].
Topics: Anti-Inflammatory Agents; Antiviral Agents; Benzimidazoles; Betacoronavirus; Betamethasone; Causalit | 2020 |
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agent | 2020 |
Hydroxychloroquine-related Rash in COVID-19 Infected Patient.
Topics: Aged; COVID-19 Drug Treatment; Drug Eruptions; Humans; Hydroxychloroquine; Male; SARS-CoV-2 | 2020 |
A 6-step rapid desensitization protocol to hydroxychloroquine.
Topics: Adult; Desensitization, Immunologic; Drug Eruptions; Female; Humans; Hydroxychloroquine; Lupus Eryth | 2021 |
Cutaneous eruption with reactive endothelial atypia due to emerging targeted cancer therapies: Report of two cases with clinico-pathologic correlation.
Topics: Adrenal Cortex Hormones; Aged; Antineoplastic Agents; Benzothiazoles; Biopsy; Drug Eruptions; Enzyme | 2021 |
Hydroxychloroquine-induced acute generalized exanthematous pustulosis: an adverse reaction to keep in mind during COVID-19 pandemic.
Topics: Adult; Antimalarials; COVID-19 Drug Treatment; Drug Eruptions; Female; Humans; Hydroxychloroquine | 2021 |
[Drug-induced toxidermia in a patient receiving hydroxychloroquine as systemic therapy for primary Gougerot-Sjögren syndrome: a case report].
Topics: Adult; Antirheumatic Agents; Drug Eruptions; Female; Humans; Hydrocortisone; Hydroxychloroquine; Lor | 2021 |
Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
Topics: Adult; Age Factors; Antimalarials; Chloroquine; Cohort Studies; Databases, Factual; Dermatomyositis; | 2018 |
Hydroxychloroquine desensitization, an effective method to overcome hypersensitivity-a multicenter experience.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Desensitization, Immunologic; Drug Administ | 2018 |
A case of an acute cutaneous drug reaction with hydroxychloroquine.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents; Antirheumatic Agents; Drug Erupti | 2018 |
Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Diarrhea; Drug Eruptions; Female; Humans; Hydroxychlo | 2018 |
Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.
Topics: Adult; Antirheumatic Agents; Autoantibodies; Dermatomyositis; Drug Eruptions; Female; Humans; Hydrox | 2018 |
Type IV allergy to antimalarials can mimic cutaneous manifestations of lupus erythematosus.
Topics: Adult; Antimanic Agents; Chloroquine; Drug Eruptions; Female; Humans; Hydroxychloroquine; Lupus Eryt | 2019 |
Assessment of Antimalarial Therapy in Patients Who Are Hypersensitive to Hydroxychloroquine.
Topics: Antimalarials; Chloroquine; Drug Eruptions; Humans; Hydroxychloroquine; Retrospective Studies | 2019 |
Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antimalarials; Dermatomyositis; Drug Eruptions; Female; Follow-Up St | 2019 |
Successful short desensitization for the eruption of hydroxychloroquine.
Topics: Adult; Desensitization, Immunologic; Drug Eruptions; Female; Humans; Hydroxychloroquine; Lupus Eryth | 2019 |
[Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo].
Topics: Adrenal Cortex Hormones; Adult; Biopsy; Coloring Agents; Diagnosis, Differential; Drug Eruptions; Ge | 2013 |
Hydroxychloroquine-induced hyperpigmentation.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Eruptions; Female; Humans; Hydroxychloroquine; Hyp | 2014 |
Cutaneous Adverse Drug Reactions with Antimalarials and Allergological Skin Tests.
Topics: Adolescent; Adult; Aged; Antimalarials; Child; Chloroquine; Drug Eruptions; Female; Humans; Hydroxyc | 2015 |
[Hydroxychloroquine and DRESS].
Topics: Antirheumatic Agents; Drug Eruptions; Eosinophilia; Humans; Hydroxychloroquine; Male; Middle Aged; P | 2008 |
Case records of the Massachusetts General Hospital. Case 20-2009. A 79-year-old woman with a blistering cutaneous eruption.
Topics: Aged; Antirheumatic Agents; Blister; Diagnosis, Differential; Drug Eruptions; Female; Humans; Hydrox | 2009 |
[Acute generalized exanthematous pustulosis included by hydroxychloroquine during lupus].
Topics: Antirheumatic Agents; Drug Eruptions; Exanthema; Female; Humans; Hydroxychloroquine; Lupus Erythemat | 2010 |
A tale of two rashes.
Topics: Aged; Antihypertensive Agents; Azathioprine; Complement C4; Cryoglobulinemia; Diagnosis, Differentia | 2011 |
Desensitization to hydroxychloroquine: 4 cases.
Topics: Antirheumatic Agents; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Female; H | 2011 |
Subacute cutaneous lupus erythematosus associated with radioiodine treatment.
Topics: Aged; Dermatologic Agents; Drug Eruptions; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Io | 2012 |
Isolated hyperpigmentation of the oral mucosa due to hydroxychloroquine.
Topics: Antimalarials; Diagnosis, Differential; Drug Eruptions; Female; Humans; Hydroxychloroquine; Hyperpig | 2012 |
Acute generalized exanthematous pustulosis precipitated by hydroxychloroquine.
Topics: Acute Disease; Adult; Antimalarials; Diagnosis, Differential; Drug Eruptions; Exanthema; Female; Hum | 2004 |
Desensitization to hydroxychloroquine--experience of 4 patients.
Topics: Adult; Antirheumatic Agents; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Dr | 2006 |
Desensitization to hydroxychloroquine: alternative interpretations.
Topics: Antirheumatic Agents; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Drug Tole | 2007 |
Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR).
Topics: Anti-Infective Agents; Austria; Calcium Channel Blockers; Case-Control Studies; Diltiazem; Drug Erup | 2007 |
Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis.
Topics: Acneiform Eruptions; Anti-Inflammatory Agents; Collagen; Collagen Diseases; Drug Eruptions; Female; | 2008 |
Discoid lupus erythematosus and porphyria cutanea tarda.
Topics: Adult; Drug Eruptions; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Male; Porph | 1996 |
Generalized pustular drug rash induced by hydroxychloroquine.
Topics: Aged; Drug Eruptions; Humans; Hydroxychloroquine; Male; Pemphigus; Skin Diseases, Vesiculobullous | 1990 |
Erythema annulare centrifugum: an unusual case due to hydroxychloroquine sulfate.
Topics: Drug Eruptions; Erythema Multiforme; Female; Humans; Hydroxychloroquine; Middle Aged; Skin | 1985 |
[Electrometric demonstration of hypersensitivity to antirheumatic drugs].
Topics: Anti-Inflammatory Agents; Antimalarials; Drug Eruptions; Gold; Humans; Hydroxychloroquine; Methods; | 1970 |